AstraZeneca
-
Omicron: AstraZeneca says its Covid vaccine booster shot significantly increases level of antibodies
Scroll Staff
-
AstraZeneca’s Covid vaccine protection wanes three months after second dose, says Lancet study
Scroll Staff
-
Covishield recipients no longer allowed in restaurants, theatres in Austria
Tabassum Barnagarwala
-
A new antibody treatment may offer protection against severe Covid-19 for up to 18 months
Rebecca Aicheler, The Conversation
-
Mix-and-match vaccine schedule highly effective against Covid-19, shows Lancet study in Sweden
Scroll Staff
-
Covid-19 vaccine boosters may increase protection against new variants, research shows
Ana Valdes, The Conversation Benjamin Ollivere, The Conversation Jonathan Ball, The Conversation
-
Kerala HC asks Centre if 84-day gap between Covishield doses is due to efficacy or availability
Scroll Staff
-
Coronavirus: AstraZeneca, Pfizer vaccines effective against Delta, Kappa variants, shows study
Scroll Staff
-
Covid-19: Two doses of Oxford vaccine is 92% effective against hospitalisation, says UK
Scroll Staff
-
Mixing and matching Covid-19 vaccines may not be such a bad idea after all
Fiona Russell, The Conversation John Hart, The Conversation
-
Covid-19: Two shots of AstraZeneca vaccine 60% effective on variant first found in India, says UK
Scroll Staff
-
Covid-19: Two AstraZeneca doses around 90% effective in real-world analysis, says UK health agency
Scroll Staff
-
COVAX needs two crore vaccine doses urgently to make up for high demand in India, says WHO
Scroll Staff
-
Coronavirus: EU sues AstraZeneca for breach of vaccine delivery contract
Scroll Staff
-
Coronavirus: UK recommends alternative to AstraZeneca vaccine for under-30s
Scroll Staff
-
Top 10 coronavirus updates: Maharashtra reports nearly 60,000 cases in biggest single-day jump
Scroll Staff
-
Coronavirus: UK identifies 30 cases of blood clots in AstraZeneca vaccine recipients
Scroll Staff
-
Coronavirus: Bharat Biotech, AstraZeneca studying vaccine shots for children, says AIIMS chief
Scroll Staff
-
Covid-19: AstraZeneca revises vaccine efficacy to 76% after US body flagged outdated data in trials
Scroll Staff
-
India temporarily halts export of Covid vaccines to meet local demand as infections surge: Reports
Scroll Staff